Osteo-promoting effects of insulin-like growth factor I (IGF-I) in a mouse model of type 1 diabetes

Bone

Volumn 57, Issue 1, 2013, Pages 36-40

  Fowlkes, John L ^a   Nyman, Jeffry S ^b,c   Bunn, R Clay ^a   Jo, Chanhee ^d   Wahl, Elizabeth C ^e   Liu, Lichu ^e   Cockrell, Gael E ^a   Morris, Lindsey M ^a,f   Lumpkin, Charles K ^a   Thrailkill, Kathryn M ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^e ARKANSAS CHILDREN S HOSPITAL RESEARCH INSTITUTE   (United States)

^f VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone formation; Diabetes; Distraction osteogenesis; IGF I

Indexed keywords

GLUCOSE; INSULIN; LEPTIN; RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN C; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE STRENGTH; CONTROLLED STUDY; CORTICAL BONE; DISTRACTION OSTEOGENESIS; DRUG EFFECT; FEMALE; FEMUR; GLUCOSE BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; OSSIFICATION; THICKNESS; TIBIA; TRABECULAR BONE;

BONE FORMATION; DIABETES; DISTRACTION OSTEOGENESIS; IGF-I;

ANIMALS; DIABETES MELLITUS, TYPE 1; HYPERGLYCEMIA; INSULIN-LIKE GROWTH FACTOR I; MICE; OSTEOGENESIS;

EID: 84882775617     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2013.07.017     Document Type: Article

References (21)

1. Thrailkill K.M., Lumpkin C.K., Bunn R.C., Kemp S.F., Fowlkes J.L. Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues. Am J Physiol Endocrinol Metab 2005, 289:E735-E745.
2. Meyer H.E., Tverdal A., Falch J.A. Risk factors for hip fracture in middle-aged Norwegian women and men. Am J Epidemiol 1993, 137:1203-1211.
3. Thrailkill K.M. Insulin-like growth factor-I in diabetes mellitus: its physiology, metabolic effects, and potential clinical utility. Diabetes Technol Ther 2000, 2:69-80.
4. Ohlsson C., Bengtsson B.A., Isaksson O.G., Andreassen T.T., Slootweg M.C. Growth hormone and bone. Endocr Rev 1998, 19:55-79.
5. Thrailkill K.M., Jo C.H., Cockrell G.E., Moreau C.S., Lumpkin C.K., Fowlkes J.L., et al. Determinants of undercarboxylated and carboxylated osteocalcin concentrations in type 1 diabetes. Osteoporos Int 2012, 23(6):1799-1806.
6. Kemink S.A., Hermus A.R., Swinkels L.M., Lutterman J.A., Smals A.G. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology. J Endocrinol Invest 2000, 23:295-303.
7. Moyer-Mileur L.J., Slater H., Jordan K.C., Murray M.A. IGF-1 and IGF-binding proteins and bone mass, geometry, and strength: relation to metabolic control in adolescent girls with type 1 diabetes. J Bone Miner Res 2008, 23:1884-1891.
8. Thrailkill K.M., Liu L., Wahl E.C., Bunn R.C., Perrien D.S., Cockrell G.E., et al. Bone formation is impaired in a model of type 1 diabetes. Diabetes 2005, 54:2875-2881.
9. Fowlkes J.L., Thrailkill K.M., Liu L., Wahl E.C., Bunn R.C., Cockrell G.E., et al. Effects of systemic and local administration of recombinant human IGF-I (rhIGF-I) on de novo bone formation in an aged mouse model. J Bone Miner Res 2006, 21:1359-1366.
10. Nyman J.S., Even J.L., Jo C.H., Herbert E.G., Murry M.R., Cockrell G.E., et al. Increasing duration of type 1 diabetes perturbs the strength-structure relationship and increases brittleness of bone. Bone 2011, 48:733-740.
11. Buie H.R., Campbell G.M., Klinck R.J., MacNeil J.A., Boyd S.K. Automatic segmentation of cortical and trabecular compartments based on a dual threshold technique for in vivo micro-CT bone analysis. Bone 2007, 41:505-515.
12. Bouxsein M.L., Boyd S.K., Christiansen B.A., Guldberg R.E., Jepsen K.J., Muller R., et al. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res 2010, 25:1468-1486.
13. Turner C.H., Burr D.B. Basic biomechanical measurements of bone: a tutorial. Bone 1993, 14:595-608.
14. Follak N., Kloting I., Merk H. Influence of diabetic metabolic state on fracture healing in spontaneously diabetic rats. Diabetes Metab Res Rev 2005, 21:288-296.
15. Follak N., Kloting L., Wolf E., Merk H. Delayed remodeling in the early period of fracture healing in spontaneously diabetic BB/OK rats depending on the diabetic metabolic state. Histol Histopathol 2004, 19:473-486.
16. Hou J.C., Zernicke R.F., Barnard R.J. Effects of severe diabetes and insulin on the femoral neck of the immature rat. J Orthop Res 1993, 11:263-271.
17. Fulzele K., DiGirolamo D.J., Liu Z., Xu J., Messina J.L., Clemens T.L., et al. Disruption of the insulin-like growth factor type 1 receptor in osteoblasts enhances insulin signaling and action. J Biol Chem 2007, 282:25649-25658.
18. Agudo J., Ayuso E., Jimenez V., Salavert A., Casellas A., Tafuro S., et al. IGF-I mediates regeneration of endocrine pancreas by increasing beta cell replication through cell cycle protein modulation in mice. Diabetologia 2008, 51:1862-1872.
19. Biver E., Salliot C., Combescure C., Gossec L., Hardouin P., Legroux-Gerot I., et al. Influence of adipokines and ghrelin on bone mineral density and fracture risk: a systematic review and meta-analysis. J Clin Endocrinol Metab 2011, 96:2703-2713.
20. Idelevich A., Sato K., Baron R. What are the effects of leptin on bone and where are they exerted?. J Bone Miner Res 2013, 28:18-21.
21. Chen M.D., Yang V.C., Alexander P.S., Lin P.Y., Song Y.M. Effects of selected minerals on leptin secretion in streptozotocin-induced hyperglycemic mice. Exp Biol Med (Maywood) 2001, 226:836-840.